Biopharmx (BPMX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period TMBRQ Trex Wind-down, Inc.April 20, 2024 | seekingalpha.comTrex Wind Down Inc (TMBRQ)April 18, 2024 | investing.comBioPharmX (BPMX) Stock Soars on Potential 'Breakthrough' Acne TreatmentJuly 8, 2023 | thestreet.comForm 424B5 Timber Pharmaceuticals, - StreetInsider.comOctober 3, 2022 | streetinsider.comOutlook on the Acne Treatment Global Market, to 2027 - Rising Public Knowledge of Cosmetic Acne Treatments is Driving Growth - Yahoo FinanceSeptember 22, 2022 | finance.yahoo.comGlobal Acne Treatment Market, By Therapeutic Class, By Formulation, By Type, By Acne Type, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027 - GlobeNewswireJuly 19, 2022 | globenewswire.comTimber Pharmaceuticals, Inc. (TMBR) Stock Price Today, Quote & News - Seeking AlphaJuly 17, 2022 | seekingalpha.comForm DEF 14A Vivos Therapeutics, Inc. For: Jul 14 - StreetInsider.comJuly 14, 2022 | streetinsider.comManagement's Discussion and Analysis of the Results of Operations - Marketscreener.comMay 13, 2022 | marketscreener.comTimber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2021 Financial Results - GlobeNewswireMarch 31, 2022 | globenewswire.comTIMBER PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.comMarch 31, 2022 | marketscreener.comAcne Drugs Global Market Report 2022 - Yahoo FinanceMarch 16, 2022 | finance.yahoo.com2021 Metabolic Partnering Global Report - In-depth Understanding of Metabolic Deal Trends Since 2014 - Be - BenzingaDecember 23, 2021 | benzinga.comAramis Biosciences Launches to Address Unmet Needs in Ocular Immunology - GlobeNewswireDecember 15, 2021 | globenewswire.comForm 10-Q Timber Pharmaceuticals, For: Sep 30 - StreetInsider.comNovember 16, 2021 | streetinsider.comTimber Pharmaceuticals : Provides Business Update and Announces Third Quarter 2021 Financial Results - Form 8-K - marketscreener.comNovember 16, 2021 | marketscreener.comVenus Concept Appoints Ross J. Portaro as President of Global Sales - StreetInsider.comOctober 13, 2021 | streetinsider.comForm 8-K Venus Concept Inc. For: Oct 05 - StreetInsider.comOctober 13, 2021 | streetinsider.comVenus Concept Appoints Ross J. Portaro as President of Global Sales - GuruFocus.comOctober 12, 2021 | gurufocus.comAcne Vulgaris Pipeline: Therapeutic Assessment, Emerging Drugs, Key Pharma Players, Clinical Trials, and Growth Prospects Analysis - GlobeNewswireOctober 11, 2021 | globenewswire.comForm PRER14A NEXTGEN HEALTHCARE, INC. - StreetInsider.comAugust 31, 2021 | streetinsider.comForm PRE 14A NEXTGEN HEALTHCARE, INC. For: Oct 13 - StreetInsider.comAugust 23, 2021 | streetinsider.comTimber Pharmaceuticals Provides Business Update and Announces Second Quarter 2021 Financial Results - GlobeNewswireAugust 10, 2021 | globenewswire.comGelteq Appoints Seasoned Pharma and Tech Executive, James Pekarsky, as Chief Financial Officer - StreetInsider.comJuly 22, 2021 | streetinsider.com Remove Ads Get Biopharmx News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMX and its competitors with MarketBeat's FREE daily newsletter. Email Address BPMX Media Mentions By Week BPMX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPMX News Sentiment▼0.000.81▲Average Medical News Sentiment BPMX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPMX Articles This Week▼00▲BPMX Articles Average Week Remove Ads Get Biopharmx News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CYBN News Today NGENF News Today IBIO News Today PHGE News Today BRTX News Today PHXM News Today NBY News Today AGNPF News Today AKBLF News Today DRTSW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:BPMX) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump… a socialist? Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biopharmx Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Biopharmx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BPMX Stock Free BPMX Stock Alerts